L

LumediX

50 employees

LumediX develops nanoparticles to enhance immunoassay sensitivity.

Basic info

Industry

medical equipment manufacturing

Sectors

Biophotonics

IVD

Medical Device

Nanotechnology

Point-of-Care

Nanoparticles

Date founded

2018

Funding rounds raised

L

LumediX raised undisclosed on October 1, 2018

Investors: Agoranov

FAQ